MedPath

A pilot program for human immunodeficiency virus (HIV) and hepatitis C (HCV) testing in New South Wales (NSW) via home and community based Dried Blood Spot (DBS) self-sampling.

Not Applicable
Recruiting
Conditions
HIV
Hepatitis C
Public Health - Epidemiology
Infection - Acquired immune deficiency syndrome (AIDS / HIV)
Infection - Sexually transmitted infections
Registration Number
ACTRN12616000673448
Lead Sponsor
SW Ministry of Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
18000
Inclusion Criteria

1. Individuals aged 16 years or older who reside in NSW
2. Ability to provide independent informed consent to participate in the study, including consent to the provision of a dried blood spot sample for HIV or hepatitis C testing, willingness to complete a brief acceptability survey, and willingness to participate in and comply with the pilot program, namely the completion of registration details

*Gay and other men who have sex with men (MSM)
*People with a transgender history
*People from regions of high HIV or hepatitis C prevalence*
*People with current or previous sexual partners from regions of high HIV prevalence*

*People who identify as Aboriginal or Torres Strait Islander,
*People who have ever injected drugs, or are attended or have attended drug and alcohol services
*People with a history of incarceration (or currently incarcerated) or who are/have been clients of community correction services
*People who are or have attended mental health services
*People who are or have been homeless
*People from regions of high HCV prevalence

Exclusion Criteria

1. Individuals who do not meet the inclusion criteria outlined above
Participants who are excluded will be informed they cannot access HIV or hepatitis C testing via the DBS website and will be directed to a local GP or sexual health clinic for testing and sexual health review.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.